| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 378,772 | 388,157 | 357,890 | | Cost of Revenue | 251,134 | 252,255 | 232,073 | | | Gross Profit | 127,638 | 135,902 | 125,817 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 124,587 | 127,421 | 112,456 | | Non Recurring | 726 | 45,355 | 1,800 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,324 | (36,873) | 11,561 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 167 | 499 | (10,723) | | Earnings Before Interest And Taxes | 2,491 | (36,375) | 838 | | Interest Expense | 2,885 | 3,785 | 7,670 | | Income Before Tax | (394) | (40,159) | (6,831) | | Income Tax Expense | 121 | 661 | 187 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (516) | (40,820) | (7,018) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (516) | (40,820) | (7,018) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($516) | ($40,820) | ($7,018) |
|
0.34% Nasdaq 0.00%
Income Statement
